EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endothelial Exostosin‐1 Is Needed for Glycocalyx Integrity and Inflammatory Resolution in Acute Lung Injury

Yuki Kawasaki, Hiroyuki Tomita, Kodai Suzuki, Chihiro Takada, Hirotaka Asano, Soichiro Kano, Yugo Wakayama, Hirotsugu Fukuda, Toru Minamiyama, Genki Yoshimura, Ryo Kamidani, Yoshinori Kakino und 11 weitere

The FASEB Journal · 2026

DOI: 10.1096/fj.202601250r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Yuki Kawasaki und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Disaster Medicine, Gifu University Graduate School of Medicine, Gifu, Japan. Hauptthemen laut MEDLINE: Glycocalyx, Inflammation, N-Acetylglucosaminyltransferases, Acute Lung Injury. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), JST FOREST PROGRAM, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The endothelial glycocalyx depends on Exostosin‐1 (Ext1)‐mediated heparan sulfate synthesis; however, its endothelial cell‐autonomous role in acute inflammation remains unclear. Therefore, we examined the role of Ext1 during acute inflammation. In this study, endothelial‐specific Ext1‐deficient mice (Ext1 flox/flox and VE‐cadherin‐Cre) were generated, and their response to endotoxin challenge was investigated using transcriptomics and imaging. Transcriptomic profiling revealed downregulation of heparan sulfate‐ and glycocalyx‐related genes, with upregulation of genes associated with immune activation. Fluorescence imaging demonstrated lectin‐ and heparan sulfate‐defined glycocalyx depletion; dextran extravasation confirmed impaired barrier integrity. Ultrastructural analyses demonstrated a near‐complete absence of the luminal glycocalyx at baseline in Ext1‐deficient lungs. Following lipopolysaccharide administration, Ext1‐deficient mice exhibited altered cytokine kinetics, delayed clearance of neutrophils and CD11b + myeloid cells, increased late‐phase macrophage accumulation, and prolonged pulmonary edema, indicating impaired resolution of inflammation. Gene set enrichment analysis revealed upregulated leukocyte transendothelial migration, chemokine signaling, and vascular endothelial growth factor pathways, consistent with a persistently activated endothelial phenotype. Endothelial Ext1 is indispensable for heparan sulfate biosynthesis, endothelial glycocalyx integrity, and timely inflammation resolution. Loss of Ext1 leads to an intrinsically pro‐inflammatory endothelial state characterized by impaired heparan sulfate–dependent signaling and dysregulated leukocyte–endothelial interactions, heightened vascular permeability, and prolonged tissue injury. Our findings support glycocalyx‐targeted therapy in sepsis, acute respiratory distress syndrome, diabetes‐associated inflammation, and other conditions of endothelial vulnerability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycocalyxInflammationN-AcetylglucosaminyltransferasesAcute Lung InjuryEndothelial CellsAnimalsExostosin 1MiceMice, KnockoutMice, Inbred C57BLMaleHeparan Sulfate

Stichwörter der Autor:innen

endothelial cellsexostosin‐1glycocalyxinflammationmicrocirculation

Substanzen

Exostosin 1N-AcetylglucosaminyltransferasesHeparan Sulfate

Autor:innen und Institutionen

  • Department of Emergency and Disaster Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu, Japan.
  • Department of Infection Control, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Department of Internal Medicine, Gifu Seiryu Hospital, Gifu, Japan.
  • Department of Pharmacy, Gifu University Hospital, Gifu, Japan.

ORCID-Profile: Hideshi Okada

Förderung

  • MEXT | Japan Society for the Promotion of Science (JSPS)
  • JST FOREST PROGRAM
  • NIA NIH HHS
  • Foundation for the National Institutes of Health (FNIH)

Zitieren

APA

Kawasaki, Y., Tomita, H., Suzuki, K., Takada, C., Asano, H., Kano, S., Wakayama, Y., Fukuda, H., Minamiyama, T., Yoshimura, G., Kamidani, R., Kakino, Y., Miura, T., Kitagawa, Y., Fukuta, T., Miyake, T., Suzuki, A., Matsumoto, K., Tetsuka, N., …, & Okada, H. (2026). Endothelial Exostosin‐1 Is Needed for Glycocalyx Integrity and Inflammatory Resolution in Acute Lung Injury. The FASEB Journal. https://doi.org/10.1096/fj.202601250r

Vancouver

Kawasaki Y, Tomita H, Suzuki K, Takada C, Asano H, Kano S, et al. Endothelial Exostosin‐1 Is Needed for Glycocalyx Integrity and Inflammatory Resolution in Acute Lung Injury. The FASEB Journal. 2026. doi:10.1096/fj.202601250r

BibTeX
@article{Kawasaki2026,
  author = {Kawasaki, Yuki and Tomita, Hiroyuki and Suzuki, Kodai and Takada, Chihiro and Asano, Hirotaka and Kano, Soichiro and Wakayama, Yugo and Fukuda, Hirotsugu and Minamiyama, Toru and Yoshimura, Genki and Kamidani, Ryo and Kakino, Yoshinori and Miura, Tomotaka and Kitagawa, Yuichiro and Fukuta, Tetsuya and Miyake, Takahito and Suzuki, Akio and Matsumoto, Kazu and Tetsuka, Nobuyuki and Yoshida, Shozo and Maekawa, Yoichi and Yamaguchi, Yu and Okada, Hideshi},
  title = {Endothelial Exostosin‐1 Is Needed for Glycocalyx Integrity and Inflammatory Resolution in Acute Lung Injury},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202601250r}
}
Kostenlos starten →